BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23466486)

  • 1. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
    Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
    Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
    Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
    Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.
    Hong JH; Ahn KS; Bae E; Jeon SS; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(2):147-52. PubMed ID: 16389264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
    Galkin AV; Mullen L; Fox WD; Brown J; Duncan D; Moreno O; Madison EL; Agus DB
    Prostate; 2004 Nov; 61(3):228-35. PubMed ID: 15368474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
    Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
    Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
    Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
    Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.
    Dorai T; Gehani N; Katz A
    Mol Urol; 2000; 4(1):1-6. PubMed ID: 10851300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional role of VIP in prostate cancer progression in a xenograft model: suppression by curcumin and COX-2 inhibitor NS-398.
    Fernández-Martínez AB; Bajo AM; Valdehita A; Isabel Arenas M; Sánchez-Chapado M; Carmena MJ; Prieto JC
    Peptides; 2009 Dec; 30(12):2357-64. PubMed ID: 19772879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
    Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
    Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling.
    Wang S; Yu S; Shi W; Ge L; Yu X; Fan J; Zhang J
    IUBMB Life; 2011 Sep; 63(9):775-82. PubMed ID: 22362715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
    Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
    Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
    Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.